Protein vaccination with the HER2/neu extracellular domain plus anti-HER2/neu antibody-cytokine fusion proteins induces a protective anti-HER2/neu immune response in mice

By Cruz J.S.D.   Lau S.Y.   Ramirez E.M.   Giovanni C.D.   Forni G.   Morrison S.L.   Penichet M.L.  

Vaccine, Vol. 21, Iss. 13, 2003-03 ,pp. : 1317-1326

Elsevier

Access to resources Recommend Favorite

Comparison of the antitumor efficacies of Her-2/neu DNA vaccines inducing contrasting IgG immunity but comparable CTL activity in mice

By Lee J.Y.   Kim D.-H.   Chung Y.   Shin S.-U.   Kang C.-Y.  

Vaccine, Vol. 21, Iss. 5, 2003-01 ,pp. : 521-531

Elsevier

Access to resources Recommend Favorite

Optimization of DNA vaccination against cutaneous leishmaniasis

By Mendez S.   Belkaid Y.   Seder R.A.   Sacks D.  

Vaccine, Vol. 20, Iss. 31, 2002-11 ,pp. : 3702-3708

Elsevier

Access to resources Recommend Favorite

Cost-Effectiveness Analysis of Vaccination against Rotavirus with RIX4414 in France

By Standaert Baudouin  

Applied Health Economics and Health Policy, Vol. 6, Iss. 4, 2008-01 ,pp. : 199-216

Adis International

Access to resources Recommend Favorite

Cost-effectiveness evaluation of vaccination against Haemophilus influenzae invasive diseases in France

By Livartowski A.   Boucher J.   Detournay B.   Reinert P.  

Vaccine, Vol. 14, Iss. 6, 1996-04 ,pp. : 495-500

Elsevier

Access to resources Recommend Favorite